Short-term (1-2 mo) hormone therapy cessation before mammography

scientific article

Short-term (1-2 mo) hormone therapy cessation before mammography is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/GME.0B013E3181A5CE60
P8608Fatcat IDrelease_s3qkt7hvnvhipj63yppx2k7pae
P932PMC publication ID2783807
P698PubMed publication ID19455069
P5875ResearchGate publication ID24439675

P50authorKatherine M NewtonQ85498825
Diana BuistQ91924352
Susan D. ReedQ114942444
P2093author name stringMelissa L Anderson
Deborah Seger
Erin J Aiello Bowles
Dawn Fitzgibbons
P2860cites workInitiation and discontinuation of hormone therapy for menopausal symptoms: results from a community sample.Q51930206
Revisions in the risk-based Breast Cancer Screening Program at Group Health Cooperative.Q52475051
Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapyQ73437260
Evaluating organized breast cancer screening implementation: the prevention of late-stage disease?Q76370726
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trialQ27860743
Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast CancerQ28142158
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trialQ29615226
Short-term cessation of hormone replacement therapy and improvement of mammographic specificityQ30471234
Women's perceptions of hormone replacement therapy: risks and benefits (1980-2002). A literature review.Q33213520
Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized TrialQ34208463
Hormone therapy prescribing patterns in the United StatesQ34363410
Discontinuation of postmenopausal hormone therapyQ36369179
The impact of the Women's Health Initiative on discontinuation of postmenopausal hormone therapy: the Minnesota Heart Survey (2000-2002).Q39371676
Effect of age on reasons for initiation and discontinuation of hormone replacement therapyQ39433899
Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammographyQ40985013
Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen/Progestin Interventions (PEPI) InvestigatorsQ41611541
Prevalence and causes of persistent use of hormone replacement therapy among postmenopausal women: a follow-up studyQ44533636
Risk of cardiovascular disease by hysterectomy status, with and without oophorectomy: the Women's Health Initiative Observational StudyQ46395799
Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammographyQ46458560
Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trialQ46713495
The hysterectomized woman. Is she special? The women's health in the Lund area (WHILA) studyQ46861557
Impact of hormone therapy on false-positive recall and costs among women undergoing screening mammography.Q51923104
P433issue6
P407language of work or nameEnglishQ1860
P304page(s)1125-1131
P577publication date2009-11-01
P1433published inMenopauseQ6817295
P1476titleShort-term (1-2 mo) hormone therapy cessation before mammography
P478volume16

Reverse relations

cites work (P2860)
Q37803403Factors associated with non-compliance with hormone therapy cessation before screening mammography
Q33571609Factors associated with successful discontinuation of hormone therapy
Q34137122Mammographic breast density and tolerance for short-term postmenopausal hormone therapy suspension
Q35473768Sleep problems after short-term hormone therapy suspension: secondary analysis of a randomized trial

Search more.